Chemoinformaics analysis of (E)-9,12-DIOXODODEC-10-ENOIC ACID
| Molecular Weight | 226.272 | nRot | 10 |
| Heavy Atom Molecular Weight | 208.128 | nRig | 9 |
| Exact Molecular Weight | 226.121 | nRing | 0 |
| Solubility: LogS | -5.449 | nHRing | 0 |
| Solubility: LogP | 5.285 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 35.2503 |
| nHD | 1 | BPOL | 20.6617 |
| QED | 0.581 |
| Synth | 4.495 |
| Natural Product Likeliness | 3.419 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.009 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.494 |
| MDCK | 0.0000153 |
| BBB | 0.932 |
| PPB | 0.967799 |
| VDSS | 2.442 |
| FU | 0.0405707 |
| CYP1A2-inh | 0.683 |
| CYP1A2-sub | 0.317 |
| CYP2c19-inh | 0.374 |
| CYP2c19-sub | 0.889 |
| CYP2c9-inh | 0.239 |
| CYP2c9-sub | 0.572 |
| CYP2d6-inh | 0.149 |
| CYP2d6-sub | 0.588 |
| CYP3a4-inh | 0.431 |
| CYP3a4-sub | 0.252 |
| CL | 15.582 |
| T12 | 0.061 |
| hERG | 0.019 |
| Ames | 0.01 |
| ROA | 0.078 |
| SkinSen | 0.075 |
| Carcinogencity | 0.164 |
| EI | 0.947 |
| Respiratory | 0.245 |
| NR-Aromatase | 0.011 |
| Antiviral | No |
| Prediction | 0.563924 |